HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q2 2022
Top Holdings64 positions
BEIGENE LTD | 5.5M | $885.7M | 19.0% | $136.90 | +18.23% | 15 qtrssince 2018-Q4 | Unchanged 0 |
JD.COM INC | 8.5M | $544.9M | 11.7% | $52.21 | +15.55% | 15 qtrssince 2018-Q4 | Increased 61 |
SALESFORCE COM INC | 2.3M | $383.9M | 8.2% | $209.45 | -19.52% | 10 qtrssince 2020-Q1 | Increased 66 |
DOORDASH INC | 4.7M | $301M | 6.5% | $116.24 | -42.00% | 7 qtrssince 2020-Q4 | Increased 72 |
SEA LTD | 4.4M | $291.3M | 6.2% | $122.37 | -43.70% | 4 qtrssince 2021-Q3 | Increased 97 |
VIPSHOP HOLDINGS LIMITED | 25.1M | $248.4M | 5.3% | $11.95 | -25.32% | 6 qtrssince 2021-Q1 | Increased 68 |
LEGEND BIOTECH CORP | 4.4M | $244M | 5.2% | $47.04 | +15.74% | 9 qtrssince 2020-Q2 | Decreased 0 |
ALIBABA GROUP HLDG LTD | 1.9M | $215M | 4.6% | $106.98 | 0.00% | 1 qtr | New 85 |
KE HLDGS INC | 9.3M | $166.1M | 3.6% | $38.36 | -56.57% | 8 qtrssince 2020-Q3 | Increased 85 |
DAQO NEW ENERGY CORP | 1.9M | $134.6M | 2.9% | $65.89 | +1.94% | 2 qtrssince 2022-Q1 | Increased 84 |
MONDELEZ INTL INC | 1.9M | $115.6M | 2.5% | $33.70 | +67.77% | 15 qtrssince 2018-Q4 | Unchanged 0 |
ON HLDG AG | 6.2M | $109.7M | 2.4% | $30.90 | -42.46% | 4 qtrssince 2021-Q3 | Decreased 0 |
CYTEK BIOSCIENCES INC | 8.8M | $94M | 2.0% | $21.41 | -49.88% | 4 qtrssince 2021-Q3 | Unchanged 0 |
PINDUODUO INC | 1.4M | $86.5M | 1.9% | $61.80 | 0.00% | 1 qtr | New 68 |
I MAB | 7.2M | $81.2M | 1.7% | $47.24 | -76.97% | 8 qtrssince 2020-Q3 | Unchanged 0 |
JINKOSOLAR HLDG CO LTD | 1.1M | $78.9M | 1.7% | $53.44 | 0.00% | 1 qtr | New 68 |
IQIYI INC | 15.4M | $64.7M | 1.4% | $18.39 | -75.91% | 15 qtrssince 2018-Q4 | Decreased 0 |
YATSEN HLDG LTD | 40.5M | $62.7M | 1.3% | $10.59 | -33.91% | 7 qtrssince 2020-Q4 | Unchanged 0 |
GOSSAMER BIO INC | 7.4M | $62.1M | 1.3% | $1,330.85 | -49.69% | 14 qtrssince 2019-Q1 | Unchanged 0 |
ENFUSION INC | 5M | $50.8M | 1.1% | — | — | 3 qtrssince 2021-Q4 | Unchanged 0 |
HHLR ADVISORS, LTD. manages $4.7B across 64 positions as of Q2 2022. Top holdings: ONC (19.0%), JD (11.7%), CRM (8.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2.5/5.0.
Active quarter - 13 new positions, 13 exits, 8 increased. Top move: SE (INCREASED, conviction 97). Portfolio: $4.7B across 64 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR